We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Palm-Sized Device Quickly Detects Ebola Virus

By LabMedica International staff writers
Posted on 18 May 2016
Print article
Image: The handheld device that can detect Ebola Virus Ribonucleic Acid (Photo courtesy of KIST Europe).
Image: The handheld device that can detect Ebola Virus Ribonucleic Acid (Photo courtesy of KIST Europe).
The gold standard method for identifying the Ebola virus in a blood sample requires packaging samples in cooled containers and sending them to specialized laboratories, often far away from where patients live.

These laboratories use a method called reverse-transcription polymerase chain reaction, or RT-PCR, to check for the virus. The prolonged testing process delays detection, treatment and real-time monitoring of viral loads in body fluids that can harbor the virus even after it is no longer detected in the blood.

Scientists at the Korea Institute of Science and Technology Europe (KIST, Saarbrücken, Germany) and their colleagues have designed and tested an instrument, which could simultaneously perform four RT-PCRs that included two controls and two patient blood samples. Conventional tests require several hours to more than a day for results to come in. The new process was completed in slightly over 30 minutes. The amount of blood required was 100 nL and could potentially come from just a finger prick.

The device was shown to concurrently perform four PCRs, one positive control with both Ebola and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) RNA and one negative control. The device successfully detected the Ebola ribonucleic acid (RNA). In addition to diagnosing the illness, the test also yielded information about how many RNA copies each sample contained. In addition to diagnosing the illness, the experts say that the tool could also potentially help health care workers track patients' viral loads in semen, breast milk and eye fluids after recovery.

A comparison of threshold cycles (CT) from the two samples provided relative quantification. The entire process, which consisted of reverse transcription, PCR amplification, and melting curve analysis (MCA), was conducted in less than 37 min. The next step will be integration with a sample preparation unit to form an integrated sample-to-answer system for point-of-care infectious disease diagnostics. The study was published on April 11, 2016, in the journal Analytical Chemistry.

Related Links:
Korea Institute of Science and Technology Europe


New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Lab Sample Rotator
H5600 Revolver
New
Urine Strips
11 Parameter Urine Strips

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.